Egeland Ryan 4
4 · Cardiovascular Systems Inc · Filed Aug 11, 2021
Insider Transaction Report
Form 4
Egeland Ryan
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2021-08-09+4,438→ 60,042 total - Award
Common Stock
[F2][F3]2021-08-09+13,313→ 74,729 total
Footnotes (3)
- [F1]Restrictions lapse as to 1,480 shares on 8/13/22 and as to 1,479 shares on each of 8/13/23 and 8/13/24.
- [F2]Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2022, 2023 and 2024 versus the Company's peer group.
- [F3]Includes 798 shares acquired on 12/31/20 and 576 shares acquired on 6/30/21 pursuant to the Company's Employee Stock Purchase Plan.
Signature
/s/ Andrew Nick as Attorney-in-Fact for Ryan Egeland pursuant to Power of Attorney filed herewith.|2021-08-11